Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.35 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8561473 | 0.88 | TACR1 (0.42) | TACR1CCR5FFAR1LTB4RLTB4R2 | |
| SCHEMBL8126875 | 0.87 | CCR5 (0.42) | TACR1CCR5LTB4RLTB4R2 | |
| SCHEMBL8970404 | 0.86 | TACR1 (0.40) | TACR1LTB4RLTB4R2OPRK1CYP1A2 | |
| SCHEMBL8970472 | 0.80 | CCR5 (0.40) | TACR1CCR5 | |
| SCHEMBL8364651 | 0.77 | CCR5 (0.46) | TACR1CCR5LTB4RLTB4R2 | |
| SCHEMBL8592517 | 0.77 | TACR1 (0.38) | TACR1CCR5 | |
| SCHEMBL8970550 | 0.76 | TACR1 (0.42) | TACR1LTB4RLTB4R2OPRK1CYP1A2 | |
| SCHEMBL8314053 | 0.76 | TACR1 (0.37) | TACR1CCR5 | |
| SCHEMBL8561372 | 0.75 | F2R (0.34) | FFAR1CYP3A4CYP2D6 | |
| SCHEMBL8315120 | 0.73 | TACR2 (0.49) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5726313-A | Substituted arylaliphatic compounds, method of preparing them and pharmaceutical compositions in which they are present | SANOFI (FR) | 1998-03-10 | — | — | US | disclosed |
| EP-0700386-A1 | NEUROKININ RECEPTOR ANTAGONISTS | SANOFI (FR) | 1996-03-13 | — | — | EP | disclosed |
| WO-1995026338-A1 | NEUROKININ RECEPTOR ANTAGONISTS | SANOFI (FR) | 1995-10-05 | — | — | WO | disclosed |